CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Revenue	$ 431.7	$ 384.9
Cost of revenue	232.3	208.5
Gross profit	199.4	176.4
Operating expenses:
Selling, general and administrative	110.3	98.1
Research and development	43.2	37.6
Other charges, net	7.8	3.1
Total operating expenses	161.3	138.8
Operating income	38.1	37.6
Interest and other income (expense), net	(2.3)	(6.0)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	35.8	31.6
Income tax provision	8.4	9.9
Consolidated net income	27.4	21.7
Net income attributable to noncontrolling interest in consolidated subsidiaries	0.4	0.1
Net income attributable to Bruker Corporation	$ 27.0	$ 21.6
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.17	$ 0.14
Diluted (in dollars per share)	$ 0.17	$ 0.13
Weighted average common shares outstanding:
Basic (in shares)	155.9	159.7
Diluted (in shares)	157.0	160.5
Comprehensive income	$ 51.8	$ 37.5
Less: Comprehensive income attributable to noncontrolling interests	0.6	0.2
Comprehensive income attributable to Bruker Corporation	$ 51.2	$ 37.3
Dividend declared per common share (in dollars per share)	$ 0.04	$ 0.04
Product
Revenue	$ 352.2	$ 318.9
Cost of revenue	185.6	172.7
Service
Revenue	77.7	63.3
Cost of revenue	46.5	35.7
Other
Revenue	1.8	2.7
Cost of revenue	$ 0.2	$ 0.1